First, the type of target cells determines the effect of acetate: when acting on CD8+ T cells, ILC3s, or macrophages, acetate can enhance immune responses and promote antitumor activity 58,61,66; conversely, when acting on MDSCs, acetate can reinforce immunosuppressive signals, thereby facilitating tumor immune evasion 69. Here, CD8A is linked to neoplasm.